Robbins Farley’s CVS Health CVS Stock Holding History

Robbins Farley’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$186K	Sell	1,800 -200	-10%	-$17.9K	0.07%	67
2026 Q1	$144K	Hold	2,000	–	–	0.06%	63
2025 Q4	$159K	Hold	2,000	–	–	0.07%	63
2025 Q3	$151K	Hold	2,000	–	–	0.06%	68
2025 Q2	$138K	Hold	2,000	–	–	0.06%	60
2025 Q1	$136K	Sell	2,000 -775	-28%	-$46.4K	0.07%	60
2024 Q4	$125K	Hold	2,775	–	–	0.06%	61
2024 Q3	$174K	Hold	2,775	–	–	0.09%	63
2024 Q2	$164K	Sell	2,775 -300	-10%	-$18.8K	0.09%	63
2024 Q1	$245K	Hold	3,075	–	–	0.13%	62
2023 Q4	$243K	Hold	3,075	–	–	0.15%	60
2023 Q3	$215K	Hold	3,075	–	–	0.15%	59
2023 Q2	$213K	Hold	3,075	–	–	0.15%	56
2023 Q1	$229K	Hold	3,075	–	–	0.15%	56
2022 Q4	$287K	Hold	3,075	–	–	0.22%	52
2022 Q3	$293K	Sell	3,075 -104	-3%	-$10.3K	0.24%	54
2022 Q2	$295K	Buy	3,179 +1	+0%	+$98	0.31%	40
2022 Q1	$322K	Sell	3,178 -99	-3%	-$10.4K	0.24%	46
2021 Q4	$338K	Sell	3,277 -50	-2%	-$4.62K	0.25%	43
2021 Q3	$282K	Sell	3,327 -149	-4%	-$12.5K	0.21%	51
2021 Q2	$290K	Sell	3,476 -100	-3%	-$8.19K	0.33%	33
2021 Q1	$307K	Buy	+3,576	New	+$260K	0.27%	48

Other funds holding CVS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Robbins Farley's CVS Position: Q2 2026 in Review

Robbins Farley reduced its CVS Health (CVS) stake by 10% in Q2 2026, selling an estimated $17.9K and leaving 1,800 shares worth $186K. The position accounts for 0.07% of the portfolio, ranked #67.

Robbins Farley first reported a position in CVS in Q1 2021 and has held it in 22 quarters since. The position peaked at $338K in Q4 2021. 2,067 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

Robbins Farley held 1,800 shares of CVS Health worth $186K as of Q2 2026.
Robbins Farley sold 200 CVS Health shares in Q2 2026, an estimated $17.9K.
CVS Health made up 0.07% of Robbins Farley's portfolio in Q2 2026, its #67 holding.
Robbins Farley first reported a position in CVS Health in Q1 2021 and has held it in 22 quarters since.
Robbins Farley's CVS Health position peaked at $338K in Q4 2021.
2,067 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Robbins Farley's 13F filing for Q2 2026, filed 23 Jul 2026.